Atlas Trials

AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma

Clinical trial NCT05594914 · UNKNOWN

Trial details

NCT number
NCT05594914
Sponsor
The First Affiliated Hospital of University of South China
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2022-10-01
Primary completion
2023-12-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.